Precision pen on Lab White
ZENGLOW
BPC-157 + TB-500 + GHK-Cu
A three-peptide combination of BPC-157, TB-500 and GHK-Cu (copper tripeptide-1), synthesized to a written specification and verified at the molecular level before listing. Studied for tissue-repair signalling and dermal connective support.
Ships FREE from within Canada · No customs · no border delays.
OVERVIEW
A three-peptide blend studied in skin and repair research.
ZENGLOW combines BPC-157 and TB-500, two peptides studied in tissue-repair models, with GHK-Cu, a copper-binding tripeptide studied in skin and extracellular-matrix remodelling. The blend is studied for tissue-repair signalling, inflammatory modulation and dermal connective support.
Research interest spans angiogenic and endothelial signalling, cytoskeletal and cell-migration pathways, and collagen / ECM remodelling.
ZENGLOW is a research-grade formulation, not an authorized medicine, and Zenovate makes no claim about cosmetic or therapeutic effects in humans. Every batch is synthesized to a written specification and tested for identity, purity and stability by an independent accredited laboratory before it is listed.
SPECIFICATIONS
THE RESEARCH
Cited research areas: angiogenic / endothelial (BPC-157) and cytoskeletal (TB-500) signalling; collagen and ECM remodelling (GHK-Cu); peptide stability and formulation chemistry.
We cite the literature. We make no claims about effects or outcomes, and no comparison to prescription products.
Identity · purity · stability
TESTING & QUALITY ASSURANCE
Every batch is tested before it ships.
COMPOUND FAQ
Questions specific to ZENGLOW.
Is ZENGLOW a prescription medicine?
No. ZENGLOW is a research-grade formulation with no marketing authorization in Canada; it is not a medicine and not a substitute for one.
How do I verify what is in a ZENGLOW vial?
Every batch is tested for identity, purity and stability by an independent accredited laboratory using UPLC / HPLC, LC-MS and related methods. Our full testing methodology is published on the Lab Results page.
Why does Zenovate avoid naming prescription brands?
Because comparing a research compound to an authorized medicine would be both misleading and non-compliant; they are different categories held to different standards of evidence.
Compounded products are not evaluated by Health Canada for safety, effectiveness or quality. ZENGLOW is a research-grade formulation, not a medicine, and nothing on this page is medical advice. For adults 19 and older.